Survey of nutritional management and investigation of the relationship between amount of nutrition and outcomes for total parenteral nutrition patients : A cohort study using the medical database

Survey of nutritional management and investigation of the relationship between amount of nutrition and outcomes for total parenteral nutrition patients : A cohort study using the medical database - Survey of nutritional management and outcomes for total parenteral nutrition patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038054

Enrollment

50000

Registered

2019-11-15

Start date

2019-11-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who were managed by total parenteral nutrition

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Patients who were inserted central venous catheter from January 1, 2009 to December 31, 2018 (2)Patients aged 18 years or older

Exclusion criteria

Exclusion criteria: (1)Patients whose body weight data is missing (2)Patients whose body weight is less than 10 kg (3)Patients who were discharged within 10 days after central venous catheter insertion (4)Patients who received oral feeding or tube feeding within 10 days after central venous catheter insertion (5)Patients whose dose of parenteral nutrition was less than 5 kcal/kg/day or more than 60 kcal/kg/day on average from 4 to10 days (during 7 days) after central venous catheter insertion (6)Patients whose dose of parenteral amino acids were less than 0.1 g/kg/day or more than 3 g/kg/day on average from 4 to10 days (during 7 days) after central venous catheter insertion (7)Patients whose dose of parenteral lipids were more than 3 g/kg/day on average from 4 to10 days (during 7 days) after central venous catheter insertion

Design outcomes

Primary

Measure	Time frame
Hospital mortality	—

Secondary

Measure	Time frame
(1)Activity of daily living (2)Re-admission rate (3)Length of hospital stay	—

Countries

Japan

Contacts

Public ContactSatoru Kamoshita

Otsuka Pharmaceutical Factory, Inc. Applied Clinical Development Department

kamoshitas@otsuka.jp03-5217-5954

Outcome results